Article

Prevention of striae gravidarum with cocoa butter cream.

Department of Obstetrics and Gynaecology, University Hospital of the West Indies, Mona, Kingston, Jamaica.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (Impact Factor: 1.41). 09/2009; 108(1):65-8. DOI: 10.1016/j.ijgo.2009.08.008
Source: PubMed

ABSTRACT To determine whether cocoa butter cream is effective in preventing striae gravidarum.
This randomized, double-blind, placebo-controlled trial enrolled 300 pregnant women: 150 women received cocoa butter cream and 150 women received a placebo cream. The women were followed-up from 16 weeks of pregnancy to delivery to assess the development of striae gravidarum. Maternal height, weight, and abdominal girth were recorded at each visit. After delivery the placenta was weighed, and anthropometry and Apgar scores of the neonate were recorded.
The 2 groups had similar clinical parameters at booking. Striae gravidarum developed in 44% of patients using cocoa butter cream compared with 55% of those using placebo; the difference was not significant (chi(2)=2.8, df(1), P=0.09). Striae gravidarum were more common among younger women and those with large neonates. However, no relationship was found between development of striae and body mass index.
Cocoa butter cream does not prevent striae gravidarum. In Afro-Caribbean women, development of striae is related to young age of the mother and large neonates.

1 Bookmark
 · 
200 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Striae distensae are an extremely common, therapeutically challenging form of dermal scarring. Risk factors have been reported but much remains to be understood about their epidemiology, diagnosis and treatment. Up-to-date knowledge of the scientific research and the evidence behind both preventative and therapeutic agents is vital in order to understand striae and to offer patients the best therapeutic alternatives. We present a clinical review of the current literature concerning striae distensae and both their prevention and treatment. A systematic review of the literature was undertaken utilising MEDLINE, EMBASE and Google scholar. Articles in English, Spanish, Portuguese, Turkish and French were included. Striae distensae occur in pregnancy, puberty and obesity as well as in numerous medical conditions and following therapeutic interventions. Aetiological mechanisms proposed relate to hormones, physical stretch and structural alterations to the integument. Assessment methods include subjective visual scoring and various imaging modalities. Treatments, which we have evaluated, include topical agents used prophylactically or therapeutically as well as light and laser therapies, which have shown improvements in the appearance of striae. No high quality, randomised controlled trials evaluating treatments for striae distensae exist. Topical therapeutic agents appear to lack efficacy in the prevention of striae distensae. This article is protected by copyright. All rights reserved.
    British Journal of Dermatology 10/2013; · 3.76 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Use of topical or systemic herbs and herbal extracts (cosmeceuticals) during pregnancy and lactation period has increased in the recent years. These cosmeceuticals are not only viewed as having clinical benefits but are also generally believed to be safe by users. A small part of thousands of plants and botanical ingredients has been investigated scientifically. The purpose of this review was to provide the safety information about the dermatologic cosmeceuticals which can be used during pregnancy and lactation period.
    Deri Hastaliklari ve Frengi Arsivi 12/2013; 47(4):194-199. · 0.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the relationship between two connective tissue pathologies: striae and pelvic organ prolapse (POP).
    European Journal of Obstetrics & Gynecology and Reproductive Biology 07/2014; 180C:116-119. · 1.63 Impact Factor